Earnings Calls News and Headlines
Earnings Calls News and Headlines
Nu Skin Enterprises reported FY 2025 adjusted EPS of $1.27, a 51% increase, with full‑year revenue of $1.49 billion and Q4 revenue of $370 million, both within guidance. Operating margin rose to 6.7% and cash balance reached $240 million while debt fell to $224 million. The company highlighted its Prism IO intelligent wellness platform, targeting 100,000 device placements and a goal of 10 million households by 2030, and announced a formal market entry into India in late 2026. Guidance for 2026 projects revenue of $1.35‑$1.5 billion and EPS of $0.80‑$1.20, reflecting foreign‑exchange headwinds and a higher tax rate.
Agilent Technologies reported Q1 2026 core revenue of $1.8 billion, up 4.4% year‑over‑year, and non‑GAAP earnings per share of $1.36, meeting internal expectations despite a $10 million hit from a winter storm. Operating margin held at 24.6% after a 50‑basis‑point decline, while...
Revolution Medicines reported that its lead KRAS inhibitor doraxonrasib secured breakthrough therapy, orphan drug, and a FDA National Priority Voucher, underscoring its potential in pancreatic cancer. Phase I data revealed median overall survival of 13.1‑15.6 months and a 47% objective...
Procept Biorobotics reported a 48% year‑over‑year revenue increase to $79.2 million in Q2 2025, driven by strong U.S. growth and a 58% surge in handpiece and consumable sales. Gross margin expanded to 65.4%, up 640 basis points, while adjusted EBITDA loss narrowed...
HNI Corp reported third‑quarter 2025 non‑GAAP EPS of $1.10, a 7% year‑over‑year increase, and posted a record non‑GAAP operating margin of 10.8%. Workplace furnishings sales rose 3% organically, with segment margin surpassing 12% after a 40‑basis‑point improvement. Management reaffirmed its...
Nvidia announced a return to the consumer PC market with new low‑power system‑on‑chip devices slated for Dell, Lenovo and other OEMs. The chips combine CPU and GPU functions, aiming to extend battery life and diversify Nvidia’s revenue beyond data centers....
Soleno Therapeutics reported $190.4 million in net revenue for fiscal 2025, representing less than nine months of commercial sales of its VICAT XR therapy. The company turned profitable, posting $20.9 million net income and generating $48.7 million of operating cash in Q4, ending the...
Montrose Environmental Group reported first‑quarter 2022 revenue of $134.7 million, a modest 0.6% year‑over‑year increase, driven by strong organic growth in its measurement‑and‑analysis and remediation segments. PFAS water‑treatment and biogas services surged, while COVID‑related CTEH revenues continued to normalize below historic...
Astec Industries reported a strong Q4 2025, with adjusted EBITDA climbing 55.7% year‑over‑year to $27.1 million and net sales up 20.1% thanks to robust demand for asphalt and concrete plants and the TerraSource acquisition. The company’s backlog expanded to $449.5 million, including...
Teladoc Health reported Q2 2025 revenue of $631.9 million, a modest 1.6% decline YoY, while adjusted EBITDA reached $69.3 million, hitting the high end of guidance. Integrated care drove growth, delivering $391.5 million in revenue and expanding U.S. membership to 102.4 million, surpassing 100 million members....
Mirum Pharmaceuticals reported $521 million in 2025 net product sales, a 55% year‑over‑year increase driven by Livmarli and bile‑acid medicines, surpassing guidance. Operating expenses rose to $543 million, yet the company generated positive cash flow and ended the year with $391 million in...
Ibotta reported Q4 2025 revenue of $83.3 million, a 16% year‑over‑year decline, and non‑GAAP gross margin of 80%, down roughly 800 basis points. The company highlighted strong traction for its LiveLift pilots, with an 83% re‑up rate, and announced a...
Snowflake (SNOW) shares are clawing back losses ahead of its Feb. 25 earnings, where analysts expect a 27% year‑over‑year revenue jump to $1.25 billion and a narrower loss of $0.65 per share. The stock remains more than 30% below its year‑to‑date high,...
Addus Homecare reported a 33.3% year‑over‑year rise in adjusted EBITDA to $50.3 million in Q4 2025, driven by a 25.6% jump in total service revenue to $373.1 million. Hospice services generated roughly $70 million, representing 18.8% of quarterly revenue, with daily census climbing...
Home Depot reported fourth‑quarter sales of $38.2 billion, a 3.8% year‑over‑year decline, yet the results beat analyst expectations. Net income slipped 14.2% to $2.6 billion and operating income fell 14.4%, reflecting pressure from a sluggish housing market. Full‑year sales rose 3.2% to...
SmarTone posted an 8.4% rise in first‑half profit, with revenue climbing 2% to HK$3.56 billion, propelled by its premium 5G positioning and higher‑value device sales. 5G ARPU was twice that of 4G, while home broadband profit surged 36% and roaming revenue...
Cipher Digital, formerly Cipher Mining, reported Q4 revenue of $60 million and an adjusted loss of $0.14 per share, both missing analyst forecasts of $84.4 million and a $0.06 loss. The company announced a strategic pivot from bitcoin mining to high‑performance computing...
Portillo’s reported a 3.3% decline in fourth‑quarter same‑store sales and a 0.5% drop for the full year, driven largely by weak transaction growth in Texas. The chain announced new CEO Brett Patterson, succeeding interim CEO Mike Miles, who highlighted that...
Home Depot reported fiscal 2025 sales of $164.7 billion, a 3.2% increase over the prior year, driven by modest comparable sales growth. Fourth‑quarter sales slipped 3.8% to $38.2 billion, reflecting a shorter reporting period and lingering consumer uncertainty. Net earnings fell slightly...
Anglo American posted a 6% year‑over‑year rise in adjusted EBITDA to $6.9 billion, driven by higher copper and iron‑ore prices, while losses in its other divisions slashed net profit after tax 70% to $610 million. The company kept its final dividend at...
Telefonica posted a modest revenue rise of 1.3% in Q4 2025, reaching €9.174 billion, and delivered €2.069 billion in full‑year free cash flow. The group expanded its access base to 326.1 million, driven by fibre and 5G uptake, while adjusted EBITDA grew 2.8%...
Hims & Hers disclosed its fourth‑quarter earnings and announced that it has withdrawn the controversial GLP‑1 weight‑loss pill it briefly launched. The decision followed conversations with key ecosystem stakeholders, including regulators and partner pharmacies. The company highlighted modest revenue growth...
HMC Capital’s Energy Transition Fund, after buying Neoen’s Victorian renewable assets and battery developer Stor‑Energy, secured a KKR commitment of up to $603 million, falling short of its $1 billion target and prompting a 16% share decline. CEO David Di Pilla defended the...
Thomson Reuters reported full‑year 2025 organic revenue growth of 7%, driven by 9% expansion in its core Legal, Corporate and Tax & Accounting segments. Adjusted EBITDA margin rose to 39.2%, a 100‑basis‑point improvement, while free cash flow reached $1.95 billion. The...
Hershey (HSY) outlined a robust 2026 outlook, targeting 4‑5% net‑sales growth and 30‑35% earnings expansion. Management highlighted a 41% gross‑margin goal, supported by cocoa hedges that sit above current spot prices. The salty‑snacks segment posted 18% organic growth in Q4,...
Jazz Pharmaceuticals reported a record $1.126 billion Q3 2025 revenue, propelled by double‑digit growth in its sleep franchise and the successful launch of the rare‑disease drug Modesto. Xywav and Epidiolex sales rose 11% and 20% year‑over‑year, while oncology product Zepzelca saw an...
Mirion Technologies reported record 2025 orders exceeding $1.1 billion, a 26% year‑over‑year increase, driven by strong nuclear power demand and a $150 million large‑opportunity pipeline. Revenue rose 7.5% to $925.4 million, with adjusted EBITDA up 12% to $227.9 million and free cash flow doubling...
Cytokinetics announced rapid global regulatory clearance for MYCorzo, securing FDA, China NMPA, and European Commission approvals within a single week. The company launched the drug in the U.S. with over 700 REMS‑certified physicians and more than 12,000 customer engagements in...
Clean Energy Fuels reported adjusted EBITDA of $67.6 million for 2025, topping the high end of its $65 million guidance despite the loss of alternative fuel tax credits. GAGA loss widened to $222 million, mainly from non‑cash interest charges tied...
Astronics Corp reported record fourth‑quarter 2025 results, with revenue of $240 million, a 15 percent year‑over‑year increase, and operating margin expanding to 14.8 percent. Net income turned positive at $29 million, driven by higher gross profit, cost reductions in SG&A, and successful pricing initiatives...
Gladstone Investment Corp reported a NAV increase to $14.95 per share, driven by $1.77 per share of unrealized appreciation and $0.09 per share of realized gains. Adjusted net investment income fell to $0.21 per share, while total assets rose to...
Simpson Manufacturing reported full‑year 2025 net sales of $2.3 billion, a 4.5% increase driven primarily by pricing, modest acquisitions and favorable FX. Operating margin rose to 19.6% after $13.1 million in cost‑saving initiatives and a $12.9 million gain from asset sales. The company...
Pacific Biosciences reported Q4 2025 revenue of $44.6 million, a 14% year‑over‑year increase, driven by record consumable sales and higher Vega system placements. Consumables generated $21.6 million, up 15% YoY, pushing non‑GAAP gross margin to 40% for the quarter and the full...
Exelon Corporation reported full‑year adjusted EPS of $2.77 and GAAP EPS of $2.73, topping the midpoint of its guidance thanks to favorable weather and regulatory outcomes. The utility announced a $41.3 billion capital plan through 2029, with more than 70% earmarked...
Sila Realty Trust reported a solid Q2 2025 performance, highlighted by an EBITDARM coverage ratio of 5.31x and a 99.2% lease occupancy after removing the Stoughton asset. Cash NOI rose 1.7% to $41.9 million, while AFFO per diluted share slipped to...
UFP Technologies reported Q4 2025 revenue of $154.6 million, up 6.5% year‑over‑year, driven by 7.3% growth in its MedTech segment. A labor‑force disruption at the AJR Illinois plant added $3 million in costs, pulling gross margin down to 27.7% and shaving $0.28...
Postal Realty Trust reported Q2 2025 results that lifted full‑year AFFI guidance to $1.24‑$1.26 per share and raised same‑store cash NOI guidance to a 79% range. The REIT added 127 properties for over $60 million at a 7.8% weighted‑average cap rate...
Fidelity National Information Services (FIS) posted Q4 2025 adjusted revenue of $2.7 billion, up 6.3% year‑over‑year, and lifted its full‑year revenue growth outlook to 5.4‑5.7%. Adjusted EBITDA margin expanded to 41.8% with a sequential 200‑basis‑point improvement, while free cash flow conversion...
Albany International reported Q4 2025 revenue of $1.2 billion and full‑year sales of $4.6 billion, the strongest top line since 2012. Adjusted EBITDA rose 11% YoY to $232 million in the quarter and $859 million for the year, pushing the margin to 19.7%, a...
Rocky Brands reported record‑setting Las Vegas results in Q4 2025, with net revenue of $505 million and adjusted EBITDA of $231 million, pushing the adjusted EBITDA margin to 45.8%. Consolidated figures also rose, delivering $511.8 million in revenue and $213 million in adjusted EBITDA, while free‑cash‑flow...
Terex completed its merger with REV Group, forming a standalone specialty vehicles segment and unlocking $75 million in annual run‑rate synergies. The company delivered Q4 2025 net sales of $1.3 billion, a 6% year‑over‑year increase, and an operating margin of 9.3%. Full‑year...
Orion Engineered Carbons reported 2025 full‑year EBITDA of $248 million, surpassing its outlook thanks to stronger‑than‑expected Q4 volumes, especially in the Specialty segment. The company generated $55 million of free cash flow, driven by $64 million of working‑capital improvements and a $46 million reduction...
Realty Income reported a 4.8% increase in AFFO per share for 2024, delivering a 10.2% total operational return supported by a 5.4% dividend yield. The REIT invested $3.9 billion at a 7.4% weighted‑average cash yield, with Q4 AFFO per share of...
Revvity reported Q4 2025 revenue of $772 million, delivering 4% organic growth and a 7% rise in its diagnostics segment. Adjusted EPS came in at $1.70, topping the high end of guidance, while adjusted operating margin held at 29.7% despite...
Henry Schein reported $3.4 billion in Q4 2025 sales, a 7.7% increase and the strongest growth in over three years. Non‑GAAP operating margin held at 7.42% while cash flow from operations jumped to $381 million. Cloud‑based Dentrix Ascend reached over 11,000 subscribers,...
Xenia Hotels & Resorts reported a Q3 2025 net loss of $13.7 million while generating $42.2 million of adjusted EBITDAre and 23 cents adjusted FFO per share, an 8% YoY decline. Same‑property RevPAR was flat, but excluding the Houston market the portfolio saw...
Procore Technologies reported Q4 FY2025 revenue of $349 million, a 15.6% year‑over‑year increase, and a non‑GAAP operating margin of 15%. The company added 2,700 $100,000‑plus ARR customers, now representing 66% of total ARR, and saw free cash flow rise 69% to...
Interface Inc. reported third‑quarter net sales of $364.5 million, a 5.9% increase year over year and 4.2% on a currency‑neutral basis. Adjusted gross profit margin rose 208 basis points to 39.5%, while adjusted operating income grew 24.5% to $54.1 million and EPS...
Centene reported full‑year 2025 adjusted diluted EPS of $2.08 and a Q4 loss of $1.19 per share, impacted by a $389 million Magellan divestiture charge. Management forecast 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, driven by Medicaid...
Globus Medical reported a record $2.519 billion revenue for 2024, up 61% year‑over‑year, and a non‑GAAP EPS of $3.04, a 31% increase. Free cash flow surged 145% to $405 million, allowing the company to eliminate its remaining $1 billion merger debt by Q1 2025....
